ev3 Inc. to Present At the Morgan Stanley Global Healthcare Conference On September 14, 2009
Do you know when to trade EVVV ?
EVVV | Quote | Chart | News | PowerRating -- ev3 Inc. (Nasdaq:EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference at 1:35 p.m. Eastern Time on Monday, September 14, 2009 at the Grand Hyatt New York located at 109 East 42nd Street at Grand Central Terminal, New York, NY.
To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coil, flow diversion devices, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: ev3 Inc.
CONTACT: ev3 Inc.
Investors and Media:
Julie Tracy, Sr. Vice President, Chief Communications Officer
(949) 680-1375
jtracy@ev3.net
For full details on EV3 Inc (EVVV) EVVV. EV3 Inc (EVVV) has Short Term PowerRatings at TradingMarkets. Details on EV3 Inc (EVVV) Short Term PowerRatings is available at This Link.
- ev3 to Present at the Barclays Capital 2010 Global Healthcare Conference on March 23, 2010 - 03/16/10
- Zacks Dowgrades ev3 to Neutral; Target $16 (EVVV) - 03/04/10
- ev3, Inc. (EVVV) Corporate Event Announcement Notice - 02/24/10
- ev3, Inc. (EVVV) Corporate Event Announcement Notice - 02/23/10
- Avinger, Inc. Announces Completion of Merger With Sawtooth Labs, Inc. - 02/22/10
- More News >>


